Maternal microchimerism and type 1 diabetes in children

Gitte Lindved Petersen*, Mads Kamper-Jørgensen, Marianne Antonius Jakobsen, Sofie Dolores Holm Olsen, Christina Ellervik, Lise Tarnow, Randi Jepsen, Flemming Pociot

*Corresponding author af dette arbejde

Abstract

Fetus and mother naturally exchange cells, and small numbers of maternal cells can persist in the child for decades. The phenomenon is denoted maternal microchimerism and involves a delicate balance between increased immune surveillance and triggering of autoimmunity. We aim to investigate the association between circulatory maternal microchimerism and type 1 diabetes in children.
This case-control study includes Danish children with and without type 1 diabetes (n=69 and 578, respectively). Peripheral blood from cases, controls, and mothers was used to identify an informative indel allele for each mother-child pair. Sequence-specific quantitative polymerase chain reaction assays were used to detect and quantify maternal cells in the child’s blood.
A logistic regression model was used to test the crude association between maternal microchimerism presence and type 1 diabetes. Because our directed acyclic graph suggests that perinatal exposures can confound the estimate, we estimated the E-value for the crude estimate to evaluate the robustness to uncontrolled confounding.
Maternal microchimerism was detected in 54% of cases (34/63) and 17% of controls (80/459) corresponding to an OR of 5.6 (95% CI 3.2, 9.7) for having type 1 diabetes among children tested positive compared to negative for maternal microchimerism. A group of confounders should be associated with a >10-fold increased probability of testing positive for maternal microchimerism as well as of having type 1 diabetes to cause a spurious OR of this size (E-values OR 10.7, CI 5.9).
Presence of maternal microchimerism was more common in children with type 1 diabetes compared to controls, and the findings are unlikely to be explained fully by unadjusted confounding. To further assess the association, we will conduct adjusted analyses, include a quantitative exposure measure, and conduct sub- and sensitivity analyses. Laboratory results are currently being linked to register data to obtain information on covariates.
OriginalsprogEngelsk
Publikationsdato13 jun. 2023
StatusUdgivet - 13 jun. 2023
BegivenhedSociety for Epidemiologic Research 2023 Annual Meeting - Portland Marriott Downtown Waterfront, Portland, USA
Varighed: 13 jun. 202316 jun. 2023
Konferencens nummer: 2023
https://epiresearch.org/annual-meeting/archives-2/2023-meeting/

Konference

KonferenceSociety for Epidemiologic Research 2023 Annual Meeting
Nummer2023
LokationPortland Marriott Downtown Waterfront
Land/OmrådeUSA
ByPortland
Periode13/06/202316/06/2023
Internetadresse

Citationsformater